Joint Clinical Trials Office
An Extension Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects with Polycythemia Vera
Study Status:
Open to Enrollment
Primary Investigator:
Date: June 17, 2024
A Phase 1/2, Multicenter, Open-Label, Randomized Dose Ranging and Expansion Study of the Combination of Gilteritinib, Venetoclax & Azacitidine in Patients with Newly Diagnosed FLT3 Mutated Acute Myeloid Leukemia not Eligible for Intensive Induction Chemo
Study Status:
Open to Enrollment
Primary Investigator:
Date: June 25, 2024
Post-transplant NASH protocol to assess the development of metabolic comorbidities and disease recurrence in those transplanted for NASH cirrhosis
Study Status:
Open to Enrollment
Primary Investigator:
Date: June 25, 2024
Phase Ib/III, Open-label, Randomised Study of Capivasertib plus CDK4/6 Inhibitors & Fulvestrant vs CDK4/6 Inhibitors & Fulvestrant in HR+ & Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced, Unresectable or Metastatic Breast Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 1, 2024
A Modular Phase I/II, Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of AZD9829 as Monotherapy or in Combination in Patients with CD123-Positive Hematological Malignancies
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 1, 2024
Assessment of Colonic Oxygenation Utilizing Intra.OxTM
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 11, 2024
A Prospective, Multicenter, Randomized Clinical Investigation Evaluating GATT-Patch for Hemostasis during Minimally Invasive Liver and Gallbladder Surgery
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 11, 2024
Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) Trial (COSMID)
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 11, 2024
A Safety and Effectiveness Prospective Blinded clinical study to validate xBar system as monitoring tool for anastomotic leaks detection
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 11, 2024
An Open-Label, Single-Center, Investigator Initiated Phase 1B Trial of E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 11, 2024